Factors influencing adherence to bisphosphonates for osteoporosis.

被引：0
|
作者：
Thompson, P
Cooper, C
Carr, A
机构：
[1] Poole Hosp NHS Trust, Poole, Dorset, England
[2] Univ Southampton, MRC Epidemiol Unit, Southampton, Hants, England
[3] Clinimatrix, London, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S394 / S394
页数：1
相关论文
共 50 条
  • [41] Factors associated with drug therapy after diagnosis of osteoporosis.
    Brennan, RM
    Wactawski-Wende, J
    Crespo, CJ
    Dmochowski, J
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s100 - s100
  • [42] Calcaneal quantitative ultrasound and clinical risk factors for osteoporosis.
    Frost, ML
    Blake, GM
    Fogelman, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S287 - S287
  • [43] Acute and chronic pancreatitis are potential rise factors for osteoporosis.
    Dormann, H
    Raithel, M
    Hahn, EG
    Schneider, T
    GASTROENTEROLOGY, 2000, 118 (04) : A420 - A420
  • [44] Factors related to spinal mobility in patients with postmenopausal osteoporosis.
    Miyakoshi, N
    Hongo, M
    Maekawa, S
    Ishikawa, Y
    Itoi, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S451 - S451
  • [45] Fall risk factors are increased in older women with osteoporosis.
    Carter, ND
    Khan, KM
    Riddell, L
    Mallinson, A
    Waterman, C
    Janssen, P
    Heinonen, A
    Kruse, K
    Prior, JC
    McKay, HA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S438 - S438
  • [46] REAL WORLD PERSISTENCE AND ADHERENCE WITH ORAL BISPHOSPHONATES FOR OSTEOPOROSIS - A SYSTEMATIC REVIEW
    Fatoye, F.
    Smith, P.
    Gebrye, T.
    Yeowell, G.
    VALUE IN HEALTH, 2018, 21 : S302 - S303
  • [47] Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates
    Fobelo Lozano, Maria Jose
    Sanchez-Fidalgo, Susana
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2019, 26 (01) : 4 - 9
  • [48] Risk factor for the Non-Responder of Bisphosphonates and Active Vitamin D Analog for the Treatment of Osteoporosis.
    Kinoshita, Mayuko
    Ishijima, Muneaki
    Sakamoto, Yuko
    Nojiri, Hidetoshi
    Liz, Liu
    Kaneko, Haruka
    Sadatsuki, Ryo
    Hada, Shinnosuke
    Kaneko, Kazuo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S194 - S194
  • [49] COST-EFFECTIVENESS OF INCREASING BISPHOSPHONATES ADHERENCE FOR OSTEOPOROSIS IN COMMUNITY PHARMACIES
    van Boven, J. F. M.
    Oosterhof, P.
    Hiddink, E. G.
    Stuurman-Bieze, A. G. G.
    Postma, M. J.
    Vegter, S.
    VALUE IN HEALTH, 2011, 14 (07) : A310 - A310
  • [50] Intravenous bisphosphonates for post-menopausal osteoporosis: adherence to a network guideline
    Yeh, Y.
    Slovik, D.
    Carter, D.
    Clapp, M.
    Churchill, W.
    Reddy, P.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 342 - 347
12345